Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4NET

Crystal structure of ADC-1 beta-lactamase

Summary for 4NET
Entry DOI10.2210/pdb4net/pdb
DescriptorAmpC, NITRATE ION, GLYCEROL, ... (4 entities in total)
Functional Keywordsbeta-lactamase, antibiotic resistance, apo enzyme, hydrolase
Biological sourceAcinetobacter baumannii
Total number of polymer chains2
Total formula weight81883.22
Authors
Bhattacharya, M.,Toth, M.,Antunes, N.T.,Smith, C.A.,Vakulenko, S.B. (deposition date: 2013-10-30, release date: 2014-03-12, Last modification date: 2024-02-28)
Primary citationBhattacharya, M.,Toth, M.,Antunes, N.T.,Smith, C.A.,Vakulenko, S.B.
Structure of the extended-spectrum class C beta-lactamase ADC-1 from Acinetobacter baumannii.
Acta Crystallogr.,Sect.D, 70:760-771, 2014
Cited by
PubMed Abstract: ADC-type class C β-lactamases comprise a large group of enzymes that are encoded by genes located on the chromosome of Acinetobacter baumannii, a causative agent of serious bacterial infections. Overexpression of these enzymes renders A. baumannii resistant to various β-lactam antibiotics and thus severely compromises the ability to treat infections caused by this deadly pathogen. Here, the high-resolution crystal structure of ADC-1, the first member of this clinically important family of antibiotic-resistant enzymes, is reported. Unlike the narrow-spectrum class C β-lactamases, ADC-1 is capable of producing resistance to the expanded-spectrum cephalosporins, rendering them inactive against A. baumannii. The extension of the substrate profile of the enzyme is likely to be the result of structural differences in the R2-loop, primarily the deletion of three residues and subsequent rearrangement of the A10a and A10b helices. These structural rearrangements result in the enlargement of the R2 pocket of ADC-1, allowing it to accommodate the bulky R2 substituents of the third-generation cephalosporins, thus enhancing the catalytic efficiency of the enzyme against these clinically important antibiotics.
PubMed: 24598745
DOI: 10.1107/S1399004713033014
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.2 Å)
Structure validation

250359

PDB entries from 2026-03-11

PDB statisticsPDBj update infoContact PDBjnumon